相关实验视频
Updated: Jul 12, 2025

06:21
Assessment of the Metabolic Profile of Primary Leukemia Cells
Published on: November 21, 2018
10.5K
德克萨米他期间瘦素增加及其与儿童急性淋巴细胞白血病中饥饿和脂肪的关联
Annelienke M van Hulst1, Emma J Verwaaijen1, Sjoerd A A van den Berg2
1Pediatric Oncology, Princess Máxima Center, 3584 CS Utrecht, The Netherlands.
The Journal of clinical endocrinology and metabolism
|October 25, 2023
概括
在患有急性淋巴细胞白血病 (ALL) 的儿童接受了五天德克萨米他治疗后,瘦素,脂肪质量,饥饿,睡眠和疲劳的情况恶化. 这表明急性勒素抵抗在代谢副作用中的潜在作用.
科学领域:
- 儿科瘤学 儿科瘤学
- 内分泌学 在内分泌学.
- 代谢健康 代谢健康
背景情况:
- 患有急性淋巴细胞白血病 (ALL) 的儿童接受高剂量的甲.
- 德克萨米他治疗可能会导致儿科患者的急性副作用.
研究的目的:
- 评估为期5天的德克萨梅他疗程对儿科ALL患者的瘦素,脂肪量,BMI,饥饿,睡眠和疲劳的影响.
- 探索这些生理和症状变化之间的关联.
主要方法:
- 研究了接受维持治疗的儿科ALL患者.
- 测量BMI,脂肪质量和瘦素是在5天德克萨米他疗程之前和之后进行的.
- 父母报告的问卷评估了饥饿,疲劳和睡眠问题.
主要成果:
- 勒普丁,脂肪质量,饥饿感,疲劳感和睡眠质量在服用德克萨米他5天后明显恶化.
- 身体质量指数 (BMI) 没有显著变化.
- 在瘦素的变化与脂肪质量,BMI,饥饿,疲劳或睡眠的变化之间没有发现相关性.
结论:
- 短期,高剂量的德克萨米他显著改变了ALL儿童的瘦素,饥饿和脂肪质量.
- 了解这些机制至关重要,因为这些患者的代谢不良事件风险增加.
- 急性勒素耐药性可能导致德克萨米他诱导的代谢变化.
相关概念视频
Regulation of Food Intake
248
Short-term regulation of food intake primarily involves neural signals from the gastrointestinal (GI) tract, blood nutrient levels, and GI tract hormones. Communication between the gut and brain via vagal nerve fibers plays a significant role in evaluating the contents of the gut. Clinical studies have shown that protein ingestion produces a more prolonged response in these nerve fibers compared to an equivalent amount of glucose. Additionally, the activation of stretch receptors caused by GI...
248
Insulin: Dosing Regimen and Adverse Effects
184
Insulin-replacement therapy usually includes both long-acting insulin (basal) and short-acting insulin (to cater to postprandial needs). In a diverse group of type 1 diabetes patients, the average daily insulin dose is typically 0.5-0.7 units/kg body weight. However, obese patients and pubertal adolescents may need more due to insulin resistance.
The basal dose constitutes about 40%-50% of the total daily dose, with the rest as premeal insulin. The mealtime insulin dose should mirror...
The basal dose constitutes about 40%-50% of the total daily dose, with the rest as premeal insulin. The mealtime insulin dose should mirror...
184
Hypoglycemia and Glucagon
274
Without prolonged fasting, healthy individuals maintain blood glucose levels above 3.5 mM due to a well-adapted neuroendocrine counterregulatory system that effectively prevents acute hypoglycemia, a potentially life-threatening condition. The primary clinical scenarios for hypoglycemia encompass diabetes treatment, inappropriate production of endogenous insulin or insulin-like substances by tumors, and the use of glucose-lowering agents in non-diabetic individuals. Notably, hypoglycemia in the...
274

